Kyle Guse

Kyle Guse

atAtossa Therapeutics· In proxies 2022–2023

Pay in FY2023-23% from the year before · Atossa Therapeutics stock +66.5% the same year

Kyle Guse was paid $1.2M in FY2023 (Dec), down 23%. Atossa Therapeutics stock rose 66.5% that year.

Pay$100 in the stock at the end of FY21 → $55
Pay is from the Summary Compensation Table of each Atossa Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Atossa TherapeuticsPublic company · 4 yr
    • 2022 – Present · 4 yrStock in role -91%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?